What are the diagnostic criteria for mixed sleep apnea (Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA))?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Mixed sleep apnea is diagnosed when a patient exhibits both obstructive and central sleep apnea events during a single sleep study, with a significant proportion of both obstructive events and central events, and the diagnostic criteria include the presence of at least 5 respiratory events per hour of sleep (apnea-hypopnea index ≥ 5) as per the American Academy of Sleep Medicine guidelines 1. The diagnosis of mixed sleep apnea requires a comprehensive sleep evaluation, including overnight polysomnography, which monitors multiple physiological parameters such as airflow, respiratory effort, oxygen saturation, brain activity, and body position.

  • The gold standard for diagnosis is overnight polysomnography, which can identify both obstructive and central sleep apnea events.
  • The diagnostic criteria for mixed sleep apnea include the presence of at least 5 respiratory events per hour of sleep (apnea-hypopnea index ≥ 5), with a significant proportion of both obstructive events (where breathing effort continues against a blocked airway) and central events (where both airflow and breathing effort temporarily cease) 1.
  • Treatment typically addresses both components, often starting with continuous positive airway pressure (CPAP) therapy at pressures between 5-20 cmH2O, which may need adjustment to an adaptive servo-ventilation (ASV) device if central events persist or worsen on CPAP, as recommended by the American Academy of Sleep Medicine 1.
  • Mixed sleep apnea often emerges during treatment of obstructive sleep apnea, a phenomenon called treatment-emergent central sleep apnea, which usually resolves within weeks to months as the body adjusts to therapy. The American Academy of Sleep Medicine guidelines recommend that polysomnography for obstructive sleep apnea should include arousal-based scoring, which helps to more definitively rule out the presence of OSA in patients with symptoms of excessive daytime sleepiness, fatigue, insomnia, or other neurocognitive symptoms 1.
  • The guidelines also recommend that an in-laboratory PSG should be performed when the results of an HSAT are negative in a patient with increased risk for OSA, as identification of arousal-based respiratory events is challenging when using most HSAT devices 1.

From the Research

Diagnostic Criteria for Mixed Sleep Apnea

The diagnostic criteria for mixed sleep apnea are not explicitly defined in the provided studies. However, the studies suggest that mixed apneas are a combination of obstructive and central apneas, and their diagnosis is often based on polysomnography (PSG) results.

  • Mixed apneas are calculated together with obstructive events in diagnosing obstructive sleep apnea syndrome (SAS) 2
  • The apnea-hypopnea index (AHI) is used to diagnose obstructive sleep apnea (OSA), with an AHI of more than five events per hour of sleep considered abnormal 3
  • Mixed apneas are associated with respiratory regulation instability and are essential for OSA pathogenesis and prognosis 4
  • The clinical significance of mixed apneas needs to be specified, and their relationship with complex SAS and the indices of abnormal respiratory events per standard and revised scoring needs to be evaluated 2

Polysomnography (PSG) in Diagnosing Mixed Sleep Apnea

PSG is a crucial tool in diagnosing mixed sleep apnea, as it measures several sleep variables, including the AHI.

  • PSG in an attended setting (sleep laboratory) has been used as a reference standard for the diagnosis of OSA 3
  • The AHI measured from portable devices in-home is the sum of apneas and hypopneas per hour of time in bed, rather than of sleep 3
  • PSG may also be used for titrating continuous positive airway pressure (CPAP) to individual needs 3

Predictors of Mixed Apneas

Several predictors of mixed apneas have been identified, including:

  • AHI > 47 or lowest oxygen saturation (LSO2) < 77% 4
  • Age, sex, body mass index (BMI), smoking, drinking, hypertension, and Epworth Sleepiness Score (ESS) 4
  • The presence of central apneas, Cheyne-Stokes respiration (CSR), or periodic breathing (PB) 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Are We Underestimating the Central Components of the Mixed Apneas?-A Hypothesis for Revised Scoring.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society, 2023

Related Questions

What defines mixed sleep apnea, also known as Mixed (Obstructive and Central) Sleep Apnea?
What is the most appropriate sleep study for a high-risk OSA patient who is an airplane pilot?
What are the American Academy of Sleep Medicine (AASM) guidelines for treating mixed sleep apnea?
What treatment is recommended for a patient with mild sleep apnea and an Apnea-Hypopnea Index (AHI) of 8.4 events per hour?
What is the recommended next step for a 4-year-old girl with Trisomy 21 (Down syndrome) who has noisy breathing when supine during sleep, but no witnessed apneas or snoring?
What are the extraintestinal manifestations in Inflammatory Bowel Disease (IBD)?
What are the symptoms and treatment options for Post-Traumatic Stress Disorder (PTSD) with mild severity?
What are the extraintestinal manifestations in Inflammatory Bowel Disease (IBD)?
Can post-traumatic stress disorder (PTSD) resurface 10 years after the initial traumatic event due to life changes and triggers?
Can post-traumatic stress disorder (PTSD) resurface 10 years after the initial event due to life changes and triggers, and is emotion-focused therapy effective in treating it?
What are the risks and alternative treatments for a 32-year-old female with severe anxiety, panic attacks, depression, obsessive-compulsive disorder (OCD), fibromyalgia, migraine, and irritable bowel syndrome (IBS) who is currently taking gabapentin (Neurontin) and wants to become pregnant, considering the potential risks of gabapentin on fetal development and the ineffectiveness of previous selective serotonin reuptake inhibitor (SSRI) trials, including sertraline (Zoloft), duloxetine (Cymbalta), and buspirone (Buspar)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.